Disorders of protein metabolism and the hemostatic system
Damage to liver tissue directly affects the most important task of hepatocytes: their synthetic function. As a result of the suppression of these processes, the formation of a number of specific proteins sharply decreases in the body, which critically impacts the blood coagulation system.
First and foremost, the production of clotting system proteins drops. These include the most important procoagulants:
- Fibrinogen (factor I);
- Prothrombin (factor II);
- Proaccelerin (factor V);
- Proconvertin (factor VII);
- Christmas factor (factor IX);
- Stuart-Prower factor (factor X).
In addition to factors promoting thrombus formation, the liver is responsible for synthesizing anticoagulant proteins, such as proteins C and S. Their deficiency also introduces an imbalance into the hemostatic system.
Clinical manifestation: A decrease in the concentration of these proteins in blood plasma consistently leads to hypocoagulation. Externally and internally, this manifests as the development of a dangerous hemorrhagic syndrome, a tendency toward prolonged bleeding, and hematoma formation.
Vitamin metabolism disorders
The liver acts as the primary biochemical laboratory where inactive vitamin precursors are converted into working molecules. In hepatic insufficiency, this process is blocked at two main levels.
- Decrease in provitamin transformation. Hepatocytes lose the ability to efficiently convert precursors ingested with food into active forms. A classic example is the disruption of the biochemical conversion of $\beta$-carotene into full-fledged vitamin A.
- Inhibition of coenzyme formation. Vitamins, especially B-group vitamins, must undergo activation to become part of enzyme systems. In liver pathology, the synthesis of the following is suppressed:
- Thiamine pyrophosphate (synthesized from vitamin $B_1$);
- Flavin mononucleotide and flavin adenine dinucleotide (formed from vitamin $B_2$);
- Pyridoxal-5-phosphate (a derivative of vitamin $B_6$);
- Coenzyme A (formed from pantothenic acid).
The absence of these coenzymes causes a cascade of secondary metabolic disruptions, as the work of enzymes dependent on these active groups halts.
Mineral metabolism alterations
In hepatic failure (HF), mineral metabolism undergoes substantial and extremely diverse disorders. The metabolism of trace elements such as iron, copper, and chromium suffers first.
A striking clinical example of the link between liver pathology and mineral imbalance is hereditary hemochromatosis. In this disease, a pathological accumulation of iron occurs directly in the liver tissues. The excess metal exerts a toxic effect on cells, which over time inevitably leads to organ enlargement (hepatomegaly) and the development of cirrhosis.
Briefly: answers to topical questions
What carbohydrate metabolism changes are characteristic of severe hepatic failure?
Liver pathology is characterized by a disruption of the main glucose metabolism processes in hepatocytes.
- Suppression of glycogenesis — a decrease in glycogen synthesis.
- Decreased efficiency of glycogenolysis — disruption of glycogen breakdown.
- Disruption of gluconeogenesis — impairment of glucose formation.
Clinically, this manifests as low resistance to carbohydrate load: fasting hypoglycemia and hyperglycemia shortly after food intake.
Also, in liver lesions, including toxic dystrophies and cirrhosis, lactate utilization decreases. The accumulation of lactic acid in the blood with a decrease in pH corresponds to lactic acidosis.
How does liver pathology affect lipid metabolism and cholesterol synthesis?
Liver pathology is associated with secondary lipid metabolism disorders, fatty liver disease, and changes in the lipoprotein profile.
- In hepatitis, secondary type II dyslipoproteinemia develops; the mechanism is impaired lipid secretion.
- In primary biliary cirrhosis, secondary type II dyslipoproteinemia develops; the mechanism is impaired lipoprotein synthesis.
- Fatty liver disease, or hepatic steatosis, is characterized by the accumulation of triglycerides in the cytoplasm of hepatocytes.
- In hepatic failure, fatty liver disease is one of the links in lipid metabolism disruption: it potentiates atherogenesis and is accompanied by hypercholesterolemia with a predominance of the proatherogenic effect.
- Cholesterol synthesis occurs in the liver; statins suppress cholesterol synthesis in the liver.
Cutaneous markers of lipid metabolism disorders can include xanthomas and xanthelasmas. Their pathogenesis is associated with the accumulation of phagocytes laden with cholesterol and/or triglycerides; such manifestations are associated, among other things, with liver pathology: primary biliary cirrhosis.
Which blood plasma transport proteins, besides clotting factors, are synthesized in the liver?
According to the cited sources, besides clotting factors, the synthesis of the following blood plasma transport components is directly confirmed for the liver:
- Albumins — synthesized in the liver; transport fatty acids in blood plasma.
- Lipoproteins — their synthesis in the liver is indicated in the sources; lipoproteins transport cholesterol in blood plasma.
Sources also indicate that globulins are synthesized in the liver, but their transport function is not explicitly disclosed in the provided materials.
To memorize the clotting factors that cease to be synthesized in liver pathology, use the sequence: 1, 2, 5, 7, 9, 10 (Fibrinogen, Prothrombin, Proaccelerin, Proconvertin, Christmas factor, Stuart-Prower factor).
Class and exam questions
Why does hemorrhagic syndrome develop in liver pathology?
Due to the impaired synthetic function of hepatocytes, the production of clotting factors (I, II, V, VII, IX, X) and anticoagulants decreases, leading to blood protein hypocoagulation.
How do liver diseases affect vitamin A metabolism?
The liver's ability to transform provitamins decreases: the biochemical conversion of the precursor ($\beta$-carotene) into the active form of vitamin A is impaired.
What happens to the liver in hereditary hemochromatosis?
Excessive accumulation of iron occurs in the liver tissue, causing cell damage and ultimately leading to hepatomegaly and cirrhosis.
What else to study on this topic
- Pathogenesis of hemorrhagic syndrome development against the background of protein hypocoagulation
- Biochemical pathways of $\beta$-carotene conversion in hepatocytes
- The role of thiamine pyrophosphate and pyridoxal-5-phosphate in cellular metabolism
- Mechanisms of the toxic action of iron in hereditary hemochromatosis
- The balance between the reduction of procoagulants and anticoagulants (proteins C and S) in hepatic failure
Master the entire topic in the "Pathophysiology" course
This is a summary. The course covers everything tested in classes and exams.
- Full study guide on "Metabolic disorders in liver pathology" and 4,913 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 135 video lessons on the subject
Other topics in "Chapter 25. Typical forms of liver pathology"
Free video lessons: pathophysiologyShort lessons with lecture notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.